{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T18:40:14Z","timestamp":1790275214249,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T00:00:00Z","timestamp":1718841600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.cca.2024.119826","type":"journal-article","created":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T06:26:06Z","timestamp":1718951166000},"page":"119826","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["\u201cTranq-dope\u201d: The first fatal intoxication due to xylazine-adulterated heroin in Italy"],"prefix":"10.1016","volume":"561","author":[{"given":"Annagiulia","family":"Di Trana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Di Giorgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3332-9518","authenticated-orcid":false,"given":"Jeremy","family":"Carlier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Serra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco Paolo","family":"Busard\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Pichini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2024.119826_b0005","unstructured":"European Monitoring Centre for Drugs and Drug Abuse (EMCDDA), The drug situation in Europe up to 2023 \u2013 An overview and assessment of emerging threats and new developments (European Drug Report 2023). https:\/\/www.emcdda.europa.eu\/publications\/european-drug-report\/2023\/drug-situation-in-europe-up-to-2023_en, 2023 (accessed 2 May 2024)."},{"key":"10.1016\/j.cca.2024.119826_b0010","unstructured":"European Monitoring Centre for Drugs and Drug Abuse (EMCDDA), Heroin and other opioids \u2013 The current situation in Europe (European Drug Report 2023). https:\/\/www.emcdda.europa.eu\/publications\/european-drug-report\/2023\/heroin-and-other-opioids_en, 2023 (accessed 2 May 2024)."},{"key":"10.1016\/j.cca.2024.119826_b0015","doi-asserted-by":"crossref","first-page":"14619","DOI":"10.3390\/ijms232314619","article-title":"Molecular insights and clinical outcomes of drugs of abuse adulteration: new trends and new psychoactive substances","volume":"23","author":"Di Trana","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2024.119826_b0020","doi-asserted-by":"crossref","first-page":"E2350630","DOI":"10.1001\/jamanetworkopen.2023.50630","article-title":"Xylazine in overdose deaths and forensic drug reports in US States, 2019\u20132022","volume":"7","author":"Cano","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.cca.2024.119826_b0025","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/injuryprev-2020-043968","article-title":"Increasing presence of xylazine in heroin and\/or fentanyl deaths, Philadelphia, Pennsylvania, 2010\u20132019","volume":"27","author":"Johnson","year":"2021","journal-title":"Inj. Prev."},{"key":"10.1016\/j.cca.2024.119826_b0030","unstructured":"US Drug Enforcement Administration (DEA), The growing threat of xylazine and its mixture with illicit drugs \u2013 DEA joint intelligence report. https:\/\/www.dea.gov\/sites\/default\/files\/2022-12\/The%20Growing%20Threat%20of%20Xylazine%20and%20its%20Mixture%20with%20Illicit%20Drugs.pdf, 2022 (accessed 2 May 2024)."},{"key":"10.1016\/j.cca.2024.119826_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.forsciint.2014.03.015","article-title":"Xylazine intoxication in humans and its importance as an emerging adulterant in abused drugs: a comprehensive review of the literature","volume":"240","author":"Ruiz-Col\u00f3n","year":"2014","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.cca.2024.119826_b0040","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.brainres.2013.02.030","article-title":"Xylazine induced central antinociception mediated by endogenous opioids and \u00b5-opioid receptor, but not \u03b4- or \u03ba-opioid receptors","volume":"1506","author":"Romero","year":"2013","journal-title":"Brain Res."},{"key":"10.1016\/j.cca.2024.119826_b0045","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3109\/15563658108990293","article-title":"Human xylazine overdose: a comparative review with clonidine, phenothiazines, and tricyclic antidepressants","volume":"18","author":"Gallanosa","year":"1981","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.cca.2024.119826_b0050","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/00006565-200112000-00012","article-title":"Severe intoxication from xylazine inhalation","volume":"17","author":"Capraro","year":"2001","journal-title":"Pediatr. Emerg. Care"},{"key":"10.1016\/j.cca.2024.119826_b0055","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2885.1981.tb00715.x","article-title":"The pharmacokinetics of xylazine hydrochloride: an interspecific study","volume":"4","author":"Garcia-Villar","year":"1981","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.cca.2024.119826_b0060","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1080\/15563650.2022.2063135","article-title":"Xylazine poisoning: a systematic review","volume":"60","author":"Ball","year":"2022","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.cca.2024.119826_b0065","unstructured":"US Drug Enforcement Administration (DEA), Public safety alert \u2013 DEA reports widespread threat of fentanyl mixed with xylazine. https:\/\/www.dea.gov\/alert\/dea-reports-widespread-threat-fentanyl-mixed-xylazine, 2022 (accessed 2 May 2024)."},{"key":"10.1016\/j.cca.2024.119826_b0070","unstructured":"M.L. Gilbert, C. Maurice-Gelinas, J. Rodrigues, J. Pitre, B. Archambault, C. Leung Soo, Spotlight: The emergence of xylazine in Canada. https:\/\/www.canada.ca\/content\/dam\/hc-sc\/documents\/services\/publications\/healthy-living\/emergence-xylazine-canada\/emergence-xylazine-canada-en.pdf, 2023 (accessed 2 May 2024)."},{"key":"10.1016\/j.cca.2024.119826_b0075","unstructured":"European Monitoring Centre for Drugs and Drug Abuse (EMCDDA), European database on new drugs. https:\/\/ednd2.emcdda.europa.eu\/ednd\/login, 2024 (accessed 2 May 2024)."},{"key":"10.1016\/j.cca.2024.119826_b0080","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.858234","article-title":"Synthetic benzimidazole opioids: the emerging health challenge for European drug users","volume":"13","author":"Di Trana","year":"2022","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.cca.2024.119826_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.jflm.2023.102542","article-title":"The first drug-related Death associated with xylazine use in the UK and Europe","volume":"97","author":"Rock","year":"2023","journal-title":"J. Forensic Leg. Med."},{"key":"10.1016\/j.cca.2024.119826_b0090","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.3390\/ijms22084000","article-title":"Ultra-high performance liquid chromatography-high resolution mass spectrometry and high-sensitivity gas chromatography-mass spectrometry screening of classic drugs and new psychoactive substances and metabolites in urine of consumers","volume":"22","author":"Marchei","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2024.119826_b0095","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.aca.2008.04.043","article-title":"Interferences and contaminants encountered in modern spectrometry","volume":"627","author":"Keller","year":"2008","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.cca.2024.119826_b0100","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.2174\/1381612828666220526152259","article-title":"Liquid chromatography high-resolution mass spectrometry in forensic toxicology: What are the specifics of method development, validation and quality assurance for comprehensive screening approaches?","volume":"28","author":"Wille","year":"2022","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.cca.2024.119826_b0105","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal. Chem."},{"key":"10.1016\/j.cca.2024.119826_b0110","doi-asserted-by":"crossref","first-page":"9779","DOI":"10.1007\/s00216-013-7419-7","article-title":"Qualitative metabolism assessment and toxicological detection of xylazine, a veterinary tranquilizer and drug of abuse, in rat and human urine using GC-MS, LC-MSn, and LC-HR-MSn","volume":"405","author":"Meyer","year":"2013","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.cca.2024.119826_b0115","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13054-020-02915-5","article-title":"Revisited: Therapeutic and toxic blood concentrations of more than 1100 drugs and other xenobiotics","volume":"24","author":"Schulz","year":"2020","journal-title":"Crit. Care"},{"key":"10.1016\/j.cca.2024.119826_b0120","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.forsciint.2004.02.013","article-title":"Postmortem toxicology of drugs of abuse","volume":"142","author":"Drummer","year":"2004","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.cca.2024.119826_b0125","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/15563650.2022.2159427","article-title":"Opioid overdoses involving xylazine in emergency department patients: a multi-center study","volume":"61","author":"Love","year":"2023","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.cca.2024.119826_b0130","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12954-023-00867-x","article-title":"Public health impact and harm reduction implications of xylazine-involved overdoses: a narrative review","volume":"20","author":"Zhu","year":"2023","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.cca.2024.119826_b0135","article-title":"Perspectives of people in Philadelphia who use fentanyl\/heroin adulterated with the animal tranquilizer xylazine; Making a case for xylazine test strips","volume":"4","author":"Reed","year":"2022","journal-title":"Drug Alcohol Depend. Rep."},{"key":"10.1016\/j.cca.2024.119826_b0140","first-page":"7337","article-title":"Pharmacology and toxicology of xylazine: Quid novum?","volume":"27","author":"Malaca","year":"2023","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.cca.2024.119826_b0145","doi-asserted-by":"crossref","first-page":"1280289","DOI":"10.3389\/fphar.2023.1280289","article-title":"\u201cTranq-dope\u201d overdose and mortality: Lethality induced by fentanyl and xylazine","volume":"14","author":"Smith","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cca.2024.119826_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2023.114726","article-title":"Enhancing fentanyl antinociception and preventing tolerance with \u03b1-2 adrenoceptor agonists in rats","volume":"457","author":"Yildiz Pehlivan","year":"2024","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.cca.2024.119826_b0155","first-page":"144","article-title":"The complex and constantly evolving public health threat of new psychoactive substances in Italy: addressing the main functions of a national observatory of drugs","volume":"57","author":"Graziano","year":"2021","journal-title":"Ann. Ist. Super. Sanita"},{"key":"10.1016\/j.cca.2024.119826_b0160","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/FTD.0b013e3181dca295","article-title":"Perspectives of liquid chromatography coupled to low- and high-resolution mass spectrometry for screening, identification, and quantification of drugs in clinical and forensic toxicology","volume":"32","author":"Maurer","year":"2010","journal-title":"Ther. Drug Monit."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898124020783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898124020783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T11:44:08Z","timestamp":1720957448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898124020783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":32,"alternative-id":["S0009898124020783"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2024.119826","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cTranq-dope\u201d: The first fatal intoxication due to xylazine-adulterated heroin in Italy","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2024.119826","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"119826"}}